Skip to content
01 · Use cases— The evidence

Novartis

3 documented AI deployments at Novartis, across 2 industries. Each one links to the public source it was taken from.

Basel, Switzerland · Founded 1996 · novartis.com · WikipediaSource: Wikidata, 2026-11-01

3
deployments
on record
2
industries
Healthcare
0%
use AI agents
0 of these
18 Nov 2021
latest source date
§ 1

Public AI record

Novartis has 3 documented public AI cases on the hub, too few for a score. Clinical documentation and patient engagement are common among peers but not yet documented at Novartis.

Low confidenceBased on 3 public cases · updated 10 Nov 2026

A record score appears once Novartis has 5 documented public cases. The peer comparison below already uses what is on record.

First documented case Sept 2019, latest Nov 2021. No new deployment documented since Nov 2021. Cloud providers named: Microsoft.

§ 2

Compared with peers

Against 39 other healthcare companies on the hub.

What peers document

  1. 54%
  2. Patient engagement14 of 39 peers
    36%
  3. 28%
  4. 23%
4 of 6 patterns

Gaps against the industry

Signature use cases

No peer on the hub documents generative ai transformation or therapeutics research.

Stack and approach vs peers
  • Peer cases name Microsoft 74%, AWS 18%, GCP 8%.
  • AI agents: 0% of Novartis's cases vs 45% for peers.
  • Cases from the last 12 months: 0% vs 22% for peers.
§ 3

Deployments

3 deployments at Novartis, newest first.

  • 18 Nov 2021
    Healthcare

    Novartis revolutionizes drug discovery with Microsoft Azure AI

    Novartis · Therapeutics research · Microsoft

    Novartis has partnered with Microsoft to enhance its drug discovery processes by leveraging AI technologies provided by Azure. This collaboration enables Novartis scientists to analyze extensive datasets and effectively use machine learning tools, significantly expediting the identification of viable drug candidates. The use of advanced analytical methods allows researchers to transform tasks traditionally taking months or years into processes executed within weeks or even days.

  • 1 Oct 2019
    Pharma

    Novartis and Microsoft: Transforming Medicine with Artificial Intelligence

    Novartis · Generative AI transformation · Microsoft

    Novartis and Microsoft formed a multi-year strategic alliance to establish the Novartis AI Innovation Lab in Switzerland. The collaboration aims to bring AI capabilities to every Novartis employee and tackle hard computational problems in life sciences, including generative chemistry, image analysis for personalized therapies, and optimization of cell and gene therapies.

  • 11 Sept 2019
    Healthcare

    Novartis and Microsoft revolutionize healthcare with AI-driven collaboration

    Novartis · Therapeutics research · Microsoft

    Novartis collaborates with Microsoft to leverage AI for enhancing drug discovery and improving healthcare delivery. This partnership includes deploying AI-enabled digital health tools to accelerate detection of diseases like leprosy by analyzing medical images. The joint efforts aim to transition healthcare systems from reactive to proactive approaches. AI applications are integrated across the pharmaceutical pipeline, covering early discovery, development, manufacturing, and patient care. By extracting insights from real-world data, advancing research, and ensuring ethical adoption of AI, this initiative marks a revolutionary turning point for healthcare delivery, especially in underserved regions.

§ 4

What it builds

Therapeutics research is the most common pattern in these deployments: 2.

§ 5

Cloud providers named

Microsoft is named in 3 of these deployments.

  1. Microsoft100% of these
    3
§ 6

Industries

Novartis deployments span 2 industries.

Follow Novartis

Or to follow it from your account.